BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28232385)

  • 1. The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53.
    Menendez D; Nguyen TA; Snipe J; Resnick MA
    Mol Cancer Res; 2017 Jun; 15(6):735-743. PubMed ID: 28232385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases.
    Ng JCF; Quist J; Grigoriadis A; Malim MH; Fraternali F
    Nucleic Acids Res; 2019 Feb; 47(3):1178-1194. PubMed ID: 30624727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOBEC3G Is a p53-Dependent Restriction Factor in Respiratory Syncytial Virus Infection of Human Cells Included in the p53/Immune Axis.
    Gladwell W; Yost O; Li H; Bell WJ; Chen SH; Ward JM; Kleeberger SR; Resnick MA; Menendez D
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3.
    Minkah N; Chavez K; Shah P; Maccarthy T; Chen H; Landau N; Krug LT
    Virology; 2014 Apr; 454-455():215-26. PubMed ID: 24725948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism.
    Suspène R; Aynaud MM; Guétard D; Henry M; Eckhoff G; Marchio A; Pineau P; Dejean A; Vartanian JP; Wain-Hobson S
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4858-63. PubMed ID: 21368204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.
    Periyasamy M; Singh AK; Gemma C; Kranjec C; Farzan R; Leach DA; Navaratnam N; Pálinkás HL; Vértessy BG; Fenton TR; Doorbar J; Fuller-Pace F; Meek DW; Coombes RC; Buluwela L; Ali S
    Nucleic Acids Res; 2017 Nov; 45(19):11056-11069. PubMed ID: 28977491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.
    Nowarski R; Kotler M
    Cancer Res; 2013 Jun; 73(12):3494-8. PubMed ID: 23598277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma.
    Xu R; Zhang X; Zhang W; Fang Y; Zheng S; Yu XF
    Hepatology; 2007 Dec; 46(6):1810-20. PubMed ID: 17847074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers.
    Mas-Ponte D; Supek F
    Nat Genet; 2020 Sep; 52(9):958-968. PubMed ID: 32747826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of APOBEC3 Proteins and Catalytic Activity in Urothelial Carcinoma.
    Jaguva Vasudevan AA; Goering W; Häussinger D; Münk C
    Methods Mol Biol; 2018; 1655():97-107. PubMed ID: 28889380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
    Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
    Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOBEC3 proteins and genomic stability: the high cost of a good defense.
    Narvaiza I; Landry S; Weitzman MD
    Cell Cycle; 2012 Jan; 11(1):33-8. PubMed ID: 22157092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.
    Akre MK; Starrett GJ; Quist JS; Temiz NA; Carpenter MA; Tutt AN; Grigoriadis A; Harris RS
    PLoS One; 2016; 11(5):e0155391. PubMed ID: 27163364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC3C, a nucleolar protein induced by genotoxins, is excluded from DNA damage sites.
    Constantin D; Dubuis G; Conde-Rubio MDC; Widmann C
    FEBS J; 2022 Feb; 289(3):808-831. PubMed ID: 34528388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of cytidine deaminases.
    Navaratnam N; Sarwar R
    Int J Hematol; 2006 Apr; 83(3):195-200. PubMed ID: 16720547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC3-mediated restriction of RNA virus replication.
    Milewska A; Kindler E; Vkovski P; Zeglen S; Ochman M; Thiel V; Rajfur Z; Pyrc K
    Sci Rep; 2018 Apr; 8(1):5960. PubMed ID: 29654310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-α induces APOBEC3G, F, and A in immature dendritic cells and limits HIV-1 spread to CD4+ T cells.
    Mohanram V; Sköld AE; Bächle SM; Pathak SK; Spetz AL
    J Immunol; 2013 Apr; 190(7):3346-53. PubMed ID: 23427247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
    Bonvin M; Greeve J
    Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
    Jost S; Turelli P; Mangeat B; Protzer U; Trono D
    J Virol; 2007 Oct; 81(19):10588-96. PubMed ID: 17652382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functions, structure, and read-through alternative splicing of feline APOBEC3 genes.
    Münk C; Beck T; Zielonka J; Hotz-Wagenblatt A; Chareza S; Battenberg M; Thielebein J; Cichutek K; Bravo IG; O'Brien SJ; Löchelt M; Yuhki N
    Genome Biol; 2008; 9(3):R48. PubMed ID: 18315870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.